Findings

What do systematic reviews say?

7 questions · 7 findings · 1 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 2 · 28.6%Low 5 · 71.4%Moderate 0 · 0%High 0 · 0%

NSAID injection vs glucocorticoid injection

Resolution at 12 to 24 weeks Quinell Grade (range 0 to 4, resolved disease is grade 0) · adults (> 18 years of age) with trigger finger

NSAID injection showed no clear difference in resolution at 12 to 24 weeks Quinell Grade (range 0 to 4, resolved… compared with glucocorticoid injection (low certainty).

1 finding from 1 review

Non‐steroidal anti‐inflammatory drugs (NSAIDs) for trigger finger 2021 · Cochrane Headline outcomes only
RR 0.83 [0.62, 1.11]
2 studies · 231 participants
Low

NSAID injection vs glucocorticoid injection

Persistent moderate to severe symptoms at 12 to 24 weeks · adults (> 18 years of age) with trigger finger

NSAID injection may leads to higher persistent moderate to severe symptoms at 12 to 24 weeks compared with glucocorticoid injection (low certainty).

1 finding from 1 review

Non‐steroidal anti‐inflammatory drugs (NSAIDs) for trigger finger 2021 · Cochrane Headline outcomes only
RR 2.03 [1.19, 3.46]
2 studies · 231 participants
Low

NSAID injection vs glucocorticoid injection

Recurrence · adults (> 18 years of age) with trigger finger

It is very uncertain whether NSAID injection changes recurrence at 12 to 24 weeks compared with glucocorticoid injection (very low certainty).

1 finding from 1 review

Non‐steroidal anti‐inflammatory drugs (NSAIDs) for trigger finger 2021 · Cochrane Headline outcomes only
RR 0.07 [0.01, 0.38]
2 studies · 231 participants
Very low

NSAID injection vs glucocorticoid injection

Total active motion · adults (> 18 years of age) with trigger finger

1 finding from 1 review

Non‐steroidal anti‐inflammatory drugs (NSAIDs) for trigger finger 2021 · Cochrane Headline outcomes only
no estimate extracted
1 study · 99 participants
Low

NSAID injection vs glucocorticoid injection

Post-operative pain (residual pain, any severity) · adults (> 18 years of age) with trigger finger

NSAID injection showed no clear difference in residual pain compared with glucocorticoid injection (low certainty).

1 finding from 1 review

Non‐steroidal anti‐inflammatory drugs (NSAIDs) for trigger finger 2021 · Cochrane Headline outcomes only
RR 0.84 [0.54, 1.31]
2 studies · 231 participants
Low

NSAID injection vs glucocorticoid injection

Global assessment of treatment success · adults (> 18 years of age) with trigger finger

NSAID injection showed no clear difference in participant‐reported treatment success compared with glucocorticoid injection (low certainty).

1 finding from 1 review

Non‐steroidal anti‐inflammatory drugs (NSAIDs) for trigger finger 2021 · Cochrane Headline outcomes only
RR 0.95 [0.74, 1.23]
1 study · 121 participants
Low

NSAID injection vs glucocorticoid injection

Adverse events · adults (> 18 years of age) with trigger finger

It is very uncertain whether NSAID injection changes adverse events compared with glucocorticoid injection (very low certainty).

1 finding from 1 review

Non‐steroidal anti‐inflammatory drugs (NSAIDs) for trigger finger 2021 · Cochrane Headline outcomes only
RR 2
2 studies · 231 participants
Very low